*Images are for illustrative purposes only

Chanazone 1g Oral Powder for Horses 5g sachet (pack of 100)

Chanelle

Item no: CHANAZOPS
 
Prescription Medicine
Max 1 per customer
£80.25
Adding to basket… The item has been added
Browse other products from the Chanelle range

Chanazone 1g Oral Powder for Horses 100x5g Sachets.


Uses
The product is indicated for the treatment of musculoskeletal conditions in the horse where relief from pain and a reduction in the associated inflammation is required, e.g. in lameness associated with osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation, particularly where continued mobility is considered desirable.

It is also of value in limiting post surgical inflammation, myositis and other soft tissue inflammation.

Phenylbutazone powder can be used as an anti-pyretic where this is considered advisable e.g. in viral respiratory infections.

Dosage and administration
For oral use.

The recommended dose rate is 4.4 – 8.8 mg/kg per day.
For each 450 kg bodyweight the following dosage guide should be used according to individual response:

Day 1 - 4.4 mg phenylbutazone/kg of bodyweight twice daily, (equivalent to two sachets or 10 g of the product twice daily).
Day 2 - 4 2.2 mg phenylbutazone /kg of bodyweight twice daily, (equivalent to one sachet or 5 g of the product twice daily) followed by 2.2 mg phenylbutazone /kg of bodyweight daily, (equivalent to one sachet or 5 g of the product daily) or on alternate days as required.
If no response is evident after 4-5 days, discontinue treatment. Hay may delay the absorption of phenylbutazone and so the onset of a clinical effect. It is advisable not to administer hay immediately prior to, or during the administration of the product.

For ease of administration the product may be mixed with a quantity of bran or oats before each treatment.

The therapeutic index of phenylbutazone is low. Do not exceed the stated dose or duration of treatment.

Contra-indications, warnings, etc
Contra-indications
Do not use in animals with known hypersensitivity to the active substance.

Use is contra-indicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal ulceration or bleeding or where there is evidence of a blood dyscrasia.
Do not use in animals suffering from thyroid disease.
Do not use in animals with severe hypertonia.
Do not use in animals with lesions in the intestinal mucosa, caused by parasitic infestations.

Adverse reactions
In common with other NSAIDs that inhibit prostaglandin synthesis, there may be gastric and/or renal intolerance. This is usually associated with overdosage and such events are rare. Recovery is usual on cessation of treatment and following the initiation of supportive symptomatic therapy.
Blood dyscrasia may occur.

Ponies are very sensitive to gastric ulceration with this product, even at therapeutic doses (diarrhoea, ulceration in the mouth and hypoproteinaemia may also be seen).

If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.

If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.

Special warnings for each target species
The clinical effects of phenylbutazone can be evident for at least three days following cessation of therapy. This should be borne in mind when examining horses for soundness.

FEI regards phenylbutazone as prohibited substance, it should be administered in accordance with FEI recommendations.

Special precautions for use in animals:
Do not exceed the stated dose of 8.8 mg/kg/day as the therapeutic index of phenylbutazone is low.

Use in any animal less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided animals may require careful clinical management.

Avoid use in any dehydrated, hypovolaemic or hypotensive animal as there is a potential risk of increased renal toxicity. Keep water readily available during the treatment period to avoid dehydration.
NSAID's can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infections, appropriate concurrent antimicrobial therapy should be instigated.

Special precautions to be taken by the person administering the veterinary medicinal product to animals:
This product may cause hypersensitivity (allergic) reactions in those sensitized to phenylbutazone, either via skin contact or accidental inhalation.

People with known hypersensitivity to phenylbutazone, or any of the excipients, should avoid contact with this product.

If you develop symptoms following exposure, such as skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes, or difficulty breathing, are more serious symptoms and require urgent medical attention.

This product can be irritating to the skin and the eyes. Avoid contact with the eyes. In case of accidental eye contact, irrigate eyes with plenty of clean water. If irritation persists seek medical advice. Wash any exposed skin and hands after use.

Care should be taken to avoid ingesting the powder. In the event of accidental ingestion, seek medical advice and show the product packaging to the physician.

Use during pregnancy and lactation:
Care should be exercised if administered to pregnant mares. Although no adverse effects of phenylbutazone on the foetus or maintenance of pregnancy have been reported during field use, no definitive safety studies have been carried out in the mare. Foetotoxic effects of phenylbutazone have been recorded in experimental animal species at high dose levels.

Use phenylbutazone in pregnant and lactating mares only according to a benefit/risk assessment by the responsible veterinarian Avoid use around time of parturition.

Interaction with other medicinal products and other forms of interaction:
Do not administer other NSAID's concurrently or within 24 hours of each other.

Concurrent administration of potential nephrotoxic drugs should be avoided.

Phenylbutazone induces hepatic microsomal enzyme activity.
There is a potential risk of increased renal toxicity after concurrent administration of aminoglycosides.

Concomitant use of glucocorticoids, other NSAIDs or anticoagulants increase adverse effects of phenylbutazone.

Therapeutic efficacy of diuretics may be reduced when used in combination with phenylbutazone-containing products

Phenylbutazone is extensively bound to plasma proteins. It may displace other drugs that are highly protein bound, e.g. some sulphonomides, warfarin or it may itself be displaced to produce an increase in non-bound pharmacologically active concentrations, which can lead to toxic effects.

Concurrent therapy with other therapeutic agents should be undertaken with caution due to the risk of metabolic interactions. Phenylbutazone may interfere with the metabolism of other drugs, e.g. warfarin, barbiturates with resultant toxicity.

There is evidence to indicate that the pharmacokinetics of penicillin and gentamicin products may be affected by concurrent administration of products containing phenylbutazone, with a possible reduction of therapeutic efficacy, since tissue penetration may be reduced. The distribution in other drugs given concurrently may also be affected.

Overdose (symptoms, emergency procedures, antidotes)
Overdosing may result in gastric and large intestinal ulceration and general enteropathy. Renal papillary damage may also occur with impaired renal function. Subcutaneous oedema, especially under the jaw, may become evident due to plasma protein loss.

In case of overdose CNS effects (excitement, seizures), hematuria and acidosis were observed. There is no specific antidote. If signs of possible overdosage occur, treat the animal symptomatically.

Incompatibilities
Do not mix this product with any other veterinary medicinal product.

Withdrawal period
Not for use in horses intended for human consumption. Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation.

Pharmaceutical precautions
This veterinary medicinal product does not require any special storage conditions.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Legal category
Legal category: POM-V

Packaging quantities
5 g sachets available in packs of 100 sachets.

Shipping charges mainland GB zone1

Value Weight Delivery Charge
Over £49.00 Any Weight FREE
Under £49.00 No weight limit £4.50
Under £49.00 Under 250 grams £3.49

Most orders are despatched the same day and standard delivery is 3 to 5 working days from despatch. FAST Expedited options are available at extra cost - these usually arrive in 24-48hrs from dispatch but delays are possible during busy periods.

Postcodes outside of Zone 1 (including some areas within mainland UK) may incur extra carriage charges due to surcharges imposed by the couriers. These will be calculated on the website at the checkout.

NB: Orders placed with faster delivery must be placed before 13:00 to ensure same day dispatch (excluding weekends and bank holidays). Please also check on the product page that the items ordered show 'In Stock' otherwise your order will be delayed until the stock becomes available, which in most cases will only be 24hrs.

Estimated "Usually shipped in" information is shown against most products

Overseas orders

We no longer send goods outside of the UK.

Prescription Items

Prescription items will be sent on receipt of a valid signed and dated prescription.

Pick up

We offer a pickup service for orders placed over the phone.

Please ring us on 01833 641112 for more information.

Refrigerated Items

Refrigerated items will be sent by carrier or express delivery at a cost of £7.50, with coolpacks, unless you pay for a premium for a refrigerated delivery. We will contact you prior to despatch for your instructions.

We want you to be completely satisfied with any purchase. If not any item* can be returned to us within 14 days of receipt for exchange or refund Please give us a ring for a returns number on 01833 641112 or alternatively email sales@hyperdrug.co.uk to obtain a returns number.

*Due to legal requirements medicines may not be returned except to correct an error in despatch or in response to an "official recall". If an item is believed to be faulty it should be returned for inspection and it may be necessary to forward it to the manufacturers for testing before replacements or refunds can be authorised. This does not infringe legal rights. Please contact our customer services for a "Returns Number" which must appear on the outside of the package or it will not be accepted. We advise customers to use an insured method of shipping and to retain proof of despatch. We may refuse returns on products specially obtained or manufactured to order. Items must be returned unsoiled and unused and sent adequately packed and carriage paid.

Related Products